Results 161 to 170 of about 17,335 (211)

ADAM17, induced by Augmenter of Liver Regeneration via G protein-coupled receptor activation, transactivates epidermal growth factor-receptor and reduces classical IL-6 signaling. [PDF]

Cell Commun Signal
Voigt C, Menzel S, Dayoub R, Kubitza M, Schmutzler F, Buechler C, Eggenhofer E, Melter M, Weiss TS.   +8 more
europepmc   +1 more source

Immunomodulatory properties of human dental pulp stromal cells: the role of IL-6/JAK/STAT3 pathway and PD-L1. [PDF]

Front Immunol
Di Tinco R, Pisciotta A, Bertani G, Orlandi G, Bertoni L, Pignatti E, Bonacini M, Rossi A, Roelofs AJ, Croci S, De Bari C, Salvarani C, Carnevale G.   +12 more
europepmc   +1 more source

Hepatic Stellate Cell-derived IL-11 Exacerbates Liver Fibrosis via Interplay between HSCs and Macrophages. [PDF]

Int J Biol Sci
Zhang Y, He F, Lei M, Fan W, Liu X, Tao Y, Wang W, Wang B, Gong L, Chen J.   +9 more
europepmc   +1 more source

Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19. [PDF]

Mol Biomed
Qiao Y, Han Y, Zhao L, Gao W, Hu H, Su C, Zheng A, Sun J, Tian M, Wu Y, Bai L, Lei Y, Wu J, Zhang W, Han P, Li X, Dong C, Wang H, Liu Z, Han P.   +19 more
europepmc   +1 more source

IL-6 Blockade Enhances the Efficacy of CDK4/6 Inhibitor in BRCA1-Mutant Triple-Negative Breast Cancer Cells. [PDF]

Cells
Pan L, Shi C, Choi J, Lin J.
europepmc   +1 more source

Structure-Guided SOCS3 Peptidomimetics: Design and Functional Characterization. [PDF]

ACS Omega
Cugudda A, La Manna S, Bucciero C, Castellano G, Malfitano AM, Marasco D.   +5 more
europepmc   +1 more source

Extracellular vesicle engineering using a small scaffold protein. [PDF]

Nat Commun
Yan W, Wang S, Hao H, Lin H, Wang C, Xie S, Zhang X, Lu Y, Ding X, Chen X, Liu H, Zhang G, Wei D, Ma C, Tang C, Li X, Yu B, Hu J, Gu Z, Yu EY, Li W, Xia J, Zhang H.   +22 more
europepmc   +1 more source

High inflammatory burden may link non-albuminuric diabetic kidney disease to carotid atherosclerosis. [PDF]

Cardiovasc Diabetol
Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Cignarelli A, Genchi VA, Giorgino F, Bosco G, Di Giacomo Barbagallo F, Scicali R, Galeano F, Tumminia A, Milluzzo A, Frittitta L, Piro S, Di Pino A.   +16 more
europepmc   +1 more source

Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma. [PDF]

BMC Med
Feinberg D, Uppin V, Eid S, Fritz C, Hitomi M, Radhakrishnan A, Klatt K, Choi SH, Myers JT, Bhatt A, Stearns D, Pateva I, Burke ZDC, Huang AY, Schwartz GK, Parameswaran R.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Activation of the gp130 signaling pathway by monoclonal antibodies directed against the gp130 molecule

European Journal of Immunology, 1997
AbstractSix cytokines of the interleukin (IL)‐6 family involved in various inflammatory or tumoral diseases share the same gp130 signal transducer chain. We made a panel of anti‐gp130 monoclonal antibodies (mAb) to study the structure and function of the gp130 molecule. These mAb recognized different epitopes of the gp130 that we called A to J. Most of
P, Autissier, J, Liautard, J, Brochier, J P, Gaillard   +3 more
openaire   +2 more sources